Medtronic (MDT)

NYSE:MDT

MDT

Medtronic

RESEARCH TOOLSreports

Want to see MDT full AI Analyst Report?

Medtronic (MDT) Stock Forecast & Price Target

6,553 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

MDT Analyst Ratings

Moderate Buy

13 Buy

9 Hold

0 Sell

Based on 22 analysts giving stock ratings to

Medtronic

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

MDT Stock 12 Month Forecast

Average Price Target

$98.52

▲(14.31% Upside)

Based on 22 Wall Street analysts offering 12 month price targets for Medtronic in the last 3 months. The average price target is $98.52 with a high forecast of $120.00 and a low forecast of $80.00. The average price target represents a 14.31% change from the last price of $86.19.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"72":"$72","121":"$121","84.25":"$84.3","96.5":"$96.5","108.75":"$108.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":120,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$120.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":98.52380952380952,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$98.52</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":80,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$80.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[72,84.25,96.5,108.75,121],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,73.98,77.52000000000001,81.06,84.60000000000001,88.14,91.68,95.22,98.76,102.3,105.84,109.38,112.92,116.46000000000001,{"y":120,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,73.98,75.86798534798535,77.7559706959707,79.64395604395605,81.53194139194139,83.41992673992674,85.30791208791209,87.19589743589744,89.08388278388279,90.97186813186812,92.85985347985348,94.74783882783882,96.63582417582417,{"y":98.52380952380952,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,73.98,74.44307692307693,74.90615384615386,75.36923076923077,75.8323076923077,76.29538461538462,76.75846153846155,77.22153846153846,77.68461538461538,78.14769230769231,78.61076923076924,79.07384615384615,79.53692307692307,{"y":80,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":81.16,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":86.73,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 45,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.307,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 46,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":90.698,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":93.355,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":89.308,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":101.754,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":95.282,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":101.878,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":97.305,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":86.06,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.98,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$120.00

Average Price Target$98.52

Lowest Price Target$80.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Robbie Marcus

J.P. Morgan

$86

Hold

-0.22%

Downside

Reiterated

06/05/26

J.P. Morgan Reaffirms Their Hold Rating on Medtronic (MDT)

Richard Newitter

Truist Financial

$95→$86

Hold

-0.22%

Downside

Assigned

06/04/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Viatris (NASDAQ: VTRS), Medtronic (NYSE: MDT) and Vertex Pharmaceuticals (NASDAQ: VRTX)

Priya Sachdeva

UBS

$90→$85

Hold

-1.38%

Downside

Assigned

06/04/26

Medtronic price target lowered to $85 from $90 at UBSMedtronic price target lowered to $85 from $90 at UBS

David Rescott

Robert W. Baird

$93→$85

Hold

-1.38%

Downside

Reiterated

06/04/26

Medtronic price target lowered to $85 from $93 at BairdMedtronic price target lowered to $85 from $93 at Baird

Larry Biegelsen

Wells Fargo

$114→$102

Buy

18.34%

Upside

Assigned

06/04/26

Wells Fargo Reaffirms Their Buy Rating on Medtronic (MDT)

Vijay Kumar

Evercore ISI

$106

Buy

22.98%

Upside

Reiterated

06/04/26

Analysts Offer Insights on Healthcare Companies: Medtronic (NYSE: MDT), Arcus Biosciences (NYSE: RCUS) and Dyne Therapeutics (NASDAQ: DYN)

Ryan Zimmerman

BTIG

$90

Buy

4.42%

Upside

Upgraded

06/04/26

Medtronic upgraded to Buy from Neutral at BTIGMedtronic upgraded to Buy from Neutral at BTIG

Josh Jennings

TD Cowen

$119

Buy

38.07%

Upside

Reiterated

06/04/26

TD Cowen Keeps Their Buy Rating on Medtronic (MDT)

David Roman

Goldman Sachs

$84→$83

Hold

-3.70%

Downside

Reiterated

06/04/26

Medtronic: Balanced Risk-Reward Keeps Hold Rating as Analyst Slightly Lowers Price Target to $83

Lee Hambright

Bernstein

$112→$97

Buy

12.54%

Upside

Reiterated

06/04/26

Medtronic: Buy Rating Reaffirmed as Strong Execution Offsets Sector Multiple Compression and Price Target Trim to $97

Anthony Petrone

Mizuho Securities

$120→$100

Buy

16.02%

Upside

Reiterated

06/03/26

Mizuho cuts Medtronic target, sees recent selloff as overdoneMizuho cuts Medtronic target, sees recent selloff as overdone

Michael Matson

Needham

$120→$101

Buy

17.18%

Upside

Reiterated

06/03/26

Medtronic Maintained at Buy as Product Momentum Offsets Valuation Concerns Despite Price Target Cut to $101

Travis Steed

Bank of America Securities

$110

Buy

27.63%

Upside

Reiterated

06/03/26

Medtronic: Buy Rating Reiterated as Diverse Growth Engines Offset Hugo Challenges; $110 Price Target Maintained

Joanne Wuensch

Citi

$110

Buy

27.63%

Upside

Reiterated

06/03/26

Analysts Offer Insights on Healthcare Companies: Vanda (NASDAQ: VNDA), ArriVent BioPharma, Inc. (NASDAQ: AVBP) and Medtronic (NYSE: MDT)

Shagun Singh Chadha

RBC Capital

$118

Buy

36.91%

Upside

Reiterated

06/03/26

RBC Capital Sticks to Their Buy Rating for Medtronic (MDT)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Robbie Marcus

J.P. Morgan

$86

Hold

-0.22%

Downside

Reiterated

06/05/26

J.P. Morgan Reaffirms Their Hold Rating on Medtronic (MDT)

Richard Newitter

Truist Financial

$95→$86

Hold

-0.22%

Downside

Assigned

06/04/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Viatris (NASDAQ: VTRS), Medtronic (NYSE: MDT) and Vertex Pharmaceuticals (NASDAQ: VRTX)

Priya Sachdeva

UBS

$90→$85

Hold

-1.38%

Downside

Assigned

06/04/26

Medtronic price target lowered to $85 from $90 at UBSMedtronic price target lowered to $85 from $90 at UBS

David Rescott

Robert W. Baird

$93→$85

Hold

-1.38%

Downside

Reiterated

06/04/26

Medtronic price target lowered to $85 from $93 at BairdMedtronic price target lowered to $85 from $93 at Baird

Larry Biegelsen

Wells Fargo

$114→$102

Buy

18.34%

Upside

Assigned

06/04/26

Wells Fargo Reaffirms Their Buy Rating on Medtronic (MDT)

Vijay Kumar

Evercore ISI

$106

Buy

22.98%

Upside

Reiterated

06/04/26

Analysts Offer Insights on Healthcare Companies: Medtronic (NYSE: MDT), Arcus Biosciences (NYSE: RCUS) and Dyne Therapeutics (NASDAQ: DYN)

Ryan Zimmerman

BTIG

$90

Buy

4.42%

Upside

Upgraded

06/04/26

Medtronic upgraded to Buy from Neutral at BTIGMedtronic upgraded to Buy from Neutral at BTIG

Josh Jennings

TD Cowen

$119

Buy

38.07%

Upside

Reiterated

06/04/26

TD Cowen Keeps Their Buy Rating on Medtronic (MDT)

David Roman

Goldman Sachs

$84→$83

Hold

-3.70%

Downside

Reiterated

06/04/26

Medtronic: Balanced Risk-Reward Keeps Hold Rating as Analyst Slightly Lowers Price Target to $83

Lee Hambright

Bernstein

$112→$97

Buy

12.54%

Upside

Reiterated

06/04/26

Medtronic: Buy Rating Reaffirmed as Strong Execution Offsets Sector Multiple Compression and Price Target Trim to $97

Anthony Petrone

Mizuho Securities

$120→$100

Buy

16.02%

Upside

Reiterated

06/03/26

Mizuho cuts Medtronic target, sees recent selloff as overdoneMizuho cuts Medtronic target, sees recent selloff as overdone

Michael Matson

Needham

$120→$101

Buy

17.18%

Upside

Reiterated

06/03/26

Medtronic Maintained at Buy as Product Momentum Offsets Valuation Concerns Despite Price Target Cut to $101

Travis Steed

Bank of America Securities

$110

Buy

27.63%

Upside

Reiterated

06/03/26

Medtronic: Buy Rating Reiterated as Diverse Growth Engines Offset Hugo Challenges; $110 Price Target Maintained

Joanne Wuensch

Citi

$110

Buy

27.63%

Upside

Reiterated

06/03/26

Analysts Offer Insights on Healthcare Companies: Vanda (NASDAQ: VNDA), ArriVent BioPharma, Inc. (NASDAQ: AVBP) and Medtronic (NYSE: MDT)

Shagun Singh Chadha

RBC Capital

$118

Buy

36.91%

Upside

Reiterated

06/03/26

RBC Capital Sticks to Their Buy Rating for Medtronic (MDT)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

TRAXFirst Tracks Biotherapeutics Inc

EVMNEvommune, Inc.

MPLTMapLight Therapeutics, Inc.

MAZEMaze Therapeutics, Inc.

AAPGAscentage Pharma Group International Unsponsored ADR

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Medtronic

3 Months

Anthony PetroneMizuho Securities

Success Rate

18/25 ratings generated profit

Average Return

+3.10%

Copying Anthony Petrone's trades and holding each position for 3 Months would result in 72.00% of your transactions generating a profit, with an average return of +3.10% per trade.

1 Year

Anthony PetroneMizuho Securities

Success Rate

16/25 ratings generated profit

Average Return

+0.43%

Copying Anthony Petrone's trades and holding each position for 1 Year would result in 64.00% of your transactions generating a profit, with an average return of +0.43% per trade.

2 Years

Anthony PetroneMizuho Securities

Success Rate

15/25 ratings generated profit

Average Return

+2.57%

Copying Anthony Petrone's trades and holding each position for 2 Years would result in 60.00% of your transactions generating a profit, with an average return of +2.57% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MDT Analyst Recommendation Trends

Rating

Feb 26

Mar 26

Apr 26

May 26

Jun 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, MDT has received 27 Buy Ratings, 16 Hold Ratings, and 0 Sell Ratings. MDT average Analyst price target in the past 3 months is 98.52.

Each month's total comprises the sum of three months' worth of ratings.

MDT Financial Forecast

MDT Earnings Forecast

Next quarter’s earnings estimate for MDT is $1.39 with a range of $1.38 to $1.41. The previous quarter’s EPS was $1.55. MDT beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year MDT has Performed in-line its overall industry.

MDT Sales Forecast

Next quarter’s sales forecast for MDT is $9.56B with a range of $9.51B to $9.66B. The previous quarter’s sales results were $9.81B. MDT beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year MDT has Performed in-line its overall industry.

MDT Stock Forecast FAQ

What is MDT’s average 12-month price target, according to analysts?

Based on analyst ratings, Medtronic’s 12-month average price target is 98.52.

What is MDT’s upside potential, based on the analysts’ average price target?

Medtronic has 14.31% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is MDT a Buy, Sell or Hold?

Medtronic has a consensus rating of Moderate Buy which is based on 13 buy ratings, 9 hold ratings and 0 sell ratings.

What is Medtronic’s price target?

The average price target for Medtronic is 98.52. This is based on 22 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $120.00 ,the lowest forecast is $80.00. The average price target represents 14.31% Increase from the current price of $86.19.

What do analysts say about Medtronic?

Medtronic’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 22 Wall Streets Analysts.

How can I buy shares of MDT?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Medtronic (MDT) Stock Forecast & Price Target

MDT Analyst Ratings

MDT Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Medtronic

MDT Analyst Recommendation Trends

MDT Financial Forecast

MDT Earnings Forecast

MDT Sales Forecast

MDT Stock Forecast FAQ

Detailed List of Analyst Forecasts